Research and development

Our Research and Development in the field of HIV/AIDS targets novel strategies and innovative drug combinations to combat the global epidemic.

Virostatics' lead compound, VS411, has completed Phase I development and entered
into a multi-national Phase II clinical trial.

An aggressive Business Development Plan is identifying additional compounds and licensing opportunities for future HIV/AIDS drug Research and Development.

   
 
Contact us
             
   
 
             
 
Sylva Petrocchi
Chief Operational Officer
Viale Umberto I, 46 - Sassari, Italy
Phone: +39 3470723820
S.Petrocchi@Virostatics.com
Michael Stevens, PharmD
Chief Development Officer
25 Fieldston Road - Princeton, NJ 08540
Phone: +1 609 987-2305 - Fax: +1 609 987-2305
M.Stevens@Virostatics.com
 

Virostatics, srl - Viale Umberto I, 46 - 07100 Sassari (SS) - Italy
This site is © Copyright Virostatics, srl All Rights Reserved - webmaster: Graphia Studio, Pavia